echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > With the continuous promotion of centralized procurement, the competition in the tens of billions of stapler market is constantly intensifying

    With the continuous promotion of centralized procurement, the competition in the tens of billions of stapler market is constantly intensifying

    • Last Update: 2023-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Stapler has great advantages over traditional manual suture in surgery, and is widely used in thoracic surgery, gastrointestinal surgery, hepatobiliary surgery, urology and other surgical fields
    .
    In recent years, with the continuous growth of China's surgical volume and the increasing penetration rate of minimally invasive surgery, the industry predicts that the size of China's stapler market will be 10.
    929 billion yuan in 2022, and it is expected to reach 14.
    058 billion yuan in 2025 (CAGR=8.
    8%)
    .

     
    It is worth noting that under the continuous expansion of the stapler market, the competition in this field is also intensifying, especially with the help of centralized procurement, the stapler industry is still blowing a tide
    of price reduction.
    It is understood that in the past two years, the stapler has become one of the products with a very frequent and extensive collection, and each province/city/autonomous region has successively carried out the centralized procurement
    of stapler alone or in alliances.
    As of July 31, 2022, 29 provinces and cities in China, including Chongqing, Hunan, Yunnan, Henan, Jiangsu, Shanxi, Fujian, Chongqing, Beijing, Tianjin, Hebei, Guangdong, Shandong, Xinjiang, Hainan, and Qinghai, have carried out or participated in the collective procurement
    of staplers.

     
    Under the continuous centralized procurement, the staplier terminal price has ushered in a significant price
    reduction.
    For example, in November 2021, in the collection and procurement of staplers carried out by the 18 provincial alliances of Beijing-Tianjin-Hebei, the average reduction rate of its tube/end-end stapler was 87%, the highest reduction was 94%, and the average reduction of its hemorrhoidal stapler was 88%, and the highest reduction was 95%.


     
    At present, for stapler enterprises, centralized procurement has become a must-do problem, if they do not participate in centralized procurement, they will directly lose the market share of the centralized procurement area; If it participates in collective procurement, it may also seize opportunities and seize the market
    .
    However, in this context, how to participate in centralized procurement, how to quote, and how to enhance competitiveness in the centralized procurement environment have become new problems
    that enterprises urgently need to solve.

     
    It is understood that there are more than 100 stapler manufacturers
    in China.
    Searching on the website of the State Food and Drug Administration with the keyword "stapler", you can see 1606 registration certificate information
    .
    In addition to many enterprises, the current open stapler varieties have basically completed domestic substitution; In other low-end product markets, it has also had certain advantages
    .
    Therefore, at present, in the face of centralized procurement price reduction and fierce market competition, domestic head stapler companies are increasing research and development, laying out a new generation of stapler products, upgrading processes, improving production levels, and moving towards the high-end market
    .

     
    For example, Tesson Medical increased its R&D investment in the first half of 2022, with a total of 16.
    4667 million yuan, accounting for 15.
    51% of the operating income, an increase of 39.
    77%
    over the same period.
    In the first half of 2022, Tesson Medical's "third-generation laparoscopic cutting stapler and nail silo assembly" project entered the product trial production stage, the "second-generation extremely thick tissue minimally invasive anastomosis technology" project entered the product pilot stage, and the "electric smart stapler" obtained the NMPA product registration certificate
    .

     
    In addition, Dongxing Medical's disposable electric laparoscopic stapler products have also been approved for marketing
    in 2021.
    According to reports, its new generation of electric laparoscopic stapler products adopt electric firing transmission design, and the instrument firing and retraction are electrified, which can further improve the stability and safety
    during surgery.

     
    It is worth mentioning that in addition to innovative products, many enterprises are also purchasing intelligent and automated equipment, improving production capacity and product quality through automated production methods, and reducing costs to cope with the increasingly serious market competition and huge demand for centralized procurement
    .
    For example, Pelt Medical plans to achieve 24-hour production by installing more automated equipment for production
    , assembly and packaging.
    Tesson Medical is also promoting the development of production and manufacturing in the direction of automation and intelligence, and its first intelligent automatic production line for laparoscopic platform has entered the introduction stage and will be accepted and put into use
    in 2022.

     
    In general, safety and innovation are the clinical core needs of stapler, and to meet the needs of both, stapler manufacturers need continuous R&D investment and technology accumulation
    .
    In the future, with the continuous investment of domestic enterprises in innovation, it is expected that domestic electric staplers will be launched one after another, and seize the market of some traditional staplers with better clinical effects; But at the same time, domestic electric stapler and imported products will also compete
    more fiercely.

     
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.